Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema NUWELLIS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiNuwellis, Inc.: Nuwellis Announces Closing of $2.7 Million Public Offering6
DiNuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 20242
26.04.Nuwellis, Inc.: Nuwellis Announces Pricing of $2.7 Million Public Offering7
17.04.Nuwellis, Inc. - S-1/A, General form for registration of securities6
09.04.Nuwellis, Inc.: Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health1
26.03.Nuwellis, Inc. - 8-K, Current Report3
13.03.Nuwellis announces public offering of shares and warrants1
13.03.Nuwellis, Inc. - S-1/A, General form for registration of securities-
11.03.Nuwellis, Inc. - 10-K, Annual Report1
07.03.Nuwellis, Inc.: Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference1
06.03.Earnings call: Nuwellis reports growth and strategic initiatives for 20241
06.03.Nuwellis, Inc. - 8-K, Current Report1
05.03.Nuwellis GAAP EPS of -$2.24 misses by $0.85, revenue of $2.6M beats by $0.05M2
05.03.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results97MINNEAPOLIS, March 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...
► Artikel lesen
04.03.Earnings Preview For Nuwellis3
27.02.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 20244
22.02.Nuwellis, Inc.: Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune215MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its distribution...
► Artikel lesen
20.02.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)119MINNEAPOLIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that, effective February 20, 2024, the Company's independent directors approved equity awards under Nuwellis'...
► Artikel lesen
20.02.Nuwellis, Inc.: Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference4
08.02.Nuwellis, Inc. - S-1/A, General form for registration of securities3
Seite:  Weiter >>